172 related articles for article (PubMed ID: 2467224)
61. Pharmacological suppression of the median raphe nucleus with serotonin1A agonists, 8-OH-DPAT and buspirone, produces hippocampal theta rhythm in the rat.
Vertes RP; Kinney GG; Kocsis B; Fortin WJ
Neuroscience; 1994 May; 60(2):441-51. PubMed ID: 8072690
[TBL] [Abstract][Full Text] [Related]
62. Effects of local application of 5-HT and 8-OH-DPAT into the dorsal and median raphe nuclei on core temperature in the rat.
Hillegaart V
Psychopharmacology (Berl); 1991; 103(3):291-6. PubMed ID: 1829235
[TBL] [Abstract][Full Text] [Related]
63. Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration.
Gilbert F; Brazell C; Tricklebank MD; Stahl SM
Eur J Pharmacol; 1988 Mar; 147(3):431-9. PubMed ID: 2897920
[TBL] [Abstract][Full Text] [Related]
64. Effect of acute and repeated versus sustained administration of the 5-HT1A receptor agonist ipsapirone: electrophysiological studies in the rat hippocampus and dorsal raphe.
Dong J; de Montigny C; Blier P
Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):303-11. PubMed ID: 9303566
[TBL] [Abstract][Full Text] [Related]
65. Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome.
Smith LM; Peroutka SJ
Pharmacol Biochem Behav; 1986 Jun; 24(6):1513-9. PubMed ID: 2942947
[TBL] [Abstract][Full Text] [Related]
66. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
[TBL] [Abstract][Full Text] [Related]
67. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
[TBL] [Abstract][Full Text] [Related]
68. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.
Li Q; Wichems C; Heils A; Van De Kar LD; Lesch KP; Murphy DL
J Pharmacol Exp Ther; 1999 Dec; 291(3):999-1007. PubMed ID: 10565817
[TBL] [Abstract][Full Text] [Related]
69. 1-(2-pyrimidinyl)-piperazine may alter the effects of the 5-HT1A agonist in the learned helplessness paradigm in rats.
Martin P
Psychopharmacology (Berl); 1991; 104(2):275-8. PubMed ID: 1678895
[TBL] [Abstract][Full Text] [Related]
70. Opiate antagonists inhibit feeding induced by 8-OH-DPAT: possible mediation in the nucleus accumbens.
Fletcher PJ
Brain Res; 1991 Sep; 560(1-2):260-7. PubMed ID: 1836972
[TBL] [Abstract][Full Text] [Related]
71. Region-specific changes in 5-HT(1A) receptor-activated G-proteins in rat brain following chronic buspirone.
Sim-Selley LJ; Vogt LJ; Xiao R; Childers SR; Selley DE
Eur J Pharmacol; 2000 Feb; 389(2-3):147-53. PubMed ID: 10688978
[TBL] [Abstract][Full Text] [Related]
72. Effects of buspirone differ from those of gepirone and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on unpunished responding of pigeons.
Barrett JE; Fleck-Kandath C; Mansbach RS
Pharmacol Biochem Behav; 1988 Jul; 30(3):723-7. PubMed ID: 2905470
[TBL] [Abstract][Full Text] [Related]
73. Electrophysiological evidence for a large receptor reserve for inhibition of dorsal raphe neuronal firing by 5-HT1A agonists.
Cox RF; Meller E; Waszczak BL
Synapse; 1993 Aug; 14(4):297-304. PubMed ID: 8248853
[TBL] [Abstract][Full Text] [Related]
74. Effects of 5-HT1A selective anxiolytics on lordosis behavior: interactions with progesterone.
Mendelson SD; Gorzalka BB
Eur J Pharmacol; 1986 Dec; 132(2-3):323-6. PubMed ID: 2880737
[TBL] [Abstract][Full Text] [Related]
75. In vivo brain dialysis study of the somatodendritic release of serotonin in the Raphe nuclei of the rat: effects of 8-hydroxy-2-(di-n-propylamino)tetralin.
Adell A; Carceller A; Artigas F
J Neurochem; 1993 May; 60(5):1673-81. PubMed ID: 7682600
[TBL] [Abstract][Full Text] [Related]
76. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
Casanovas JM; Vilaró MT; Mengod G; Artigas F
J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078
[TBL] [Abstract][Full Text] [Related]
77. The dorsal raphe nucleus exerts opposed control on generalized anxiety and panic-related defensive responses in rats.
Sena LM; Bueno C; Pobbe RL; Andrade TG; Zangrossi H; Viana MB
Behav Brain Res; 2003 Jun; 142(1-2):125-33. PubMed ID: 12798273
[TBL] [Abstract][Full Text] [Related]
78. Electrophysiological assessment of putative antagonists of 5-hydroxytryptamine receptors: a single-cell study in the rat dorsal raphe nucleus.
Blier P; Steinberg S; Chaput Y; de Montigny C
Can J Physiol Pharmacol; 1989 Feb; 67(2):98-105. PubMed ID: 2523754
[TBL] [Abstract][Full Text] [Related]
79. Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis.
Hutson PH; Sarna GS; O'Connell MT; Curzon G
Neurosci Lett; 1989 May; 100(1-3):276-80. PubMed ID: 2474776
[TBL] [Abstract][Full Text] [Related]
80. Effects of 8-OH-DPAT, 5-CT and muscimol on behaviour maintained by a DRL20 schedule of reinforcement, following microinjection into the dorsal or median raphe nuclei.
Fletcher PJ
Behav Pharmacol; 1994 Jun; 5(3):326-336. PubMed ID: 11224282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
